drugset / Trial / NCT07557407

A Mass Balance Study of [14C]HRS-1780 in Healthy Adult Male Subjects

NCT07557407

Phase 1 Not yet recruiting 6 enrolled Shandong Suncadia Medicine Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The study aims to evaluate the pharmacokinetics, mass balance recovery, metabolite profile and metabolite identification of \[14C\]HRS-1780 following an oral single dose in healthy adult male participants.

Timeline

Start
2026-05
Primary completion
2026-06
Completion
2026-06

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-1780 Small molecule Oral